Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?

Published

Journal Article (Review)

The disabling and painful disease osteoarthritis (OA) is the most common form of arthritis. Strong evidence suggests that a subpopulation of OA patients has a form of OA driven by inflammation. Consequently, understanding when inflammation is the driver of disease progression and which OA patients might benefit from anti-inflammatory treatment is a topic of intense research in the OA field. We have reviewed the current literature on OA, with an emphasis on inflammation in OA, biochemical markers of structural damage, and anti-inflammatory treatments for OA. The literature suggests that the OA patient population is diverse, consisting of several subpopulations, including one associated with inflammation. This inflammatory subpopulation may be identified by a combination of novel serological inflammatory biomarkers. Preliminary evidence from small clinical studies suggests that this subpopulation may benefit from anti-inflammatory treatment currently reserved for other inflammatory arthritides.

Full Text

Duke Authors

Cited Authors

  • Siebuhr, AS; Bay-Jensen, AC; Jordan, JM; Kjelgaard-Petersen, CF; Christiansen, C; Abramson, SB; Attur, M; Berenbaum, F; Kraus, V; Karsdal, MA

Published Date

  • 2016

Published In

Volume / Issue

  • 45 / 2

Start / End Page

  • 87 - 98

PubMed ID

  • 26484849

Pubmed Central ID

  • 26484849

Electronic International Standard Serial Number (EISSN)

  • 1502-7732

Digital Object Identifier (DOI)

  • 10.3109/03009742.2015.1060259

Language

  • eng

Conference Location

  • England